Quantcast
Last updated on April 16, 2014 at 21:24 EDT

Latest UCB Stories

2012-01-13 09:30:00

ATLANTA and RED BANK, N.J., Jan. 13, 2012 /PRNewswire/ -- Millions of people in the U.S. live with chronic health conditions, and many may find it difficult to manage their condition. The Women Succeeding with Chronic Conditions health pavilion provides comprehensive information and practical solutions designed to help those touched by a chronic condition lead a full and active life. Featuring world renowned health and fitness expert Dr. Pamela Peeke--who will demonstrate exercise techniques...

2011-12-21 00:00:00

BRUSSELS, Dec. 21, 2011 /PRNewswire/ -- UCB today announced the start of the EXXELERATE(TM) study which will evaluate the short- and long-term efficacy of Cimzia® (certolizumab pegol) plus methotrexate (MTX) compared with that of Humira®* (adalimumab) plus MTX in the treatment of moderate to severe rheumatoid arthritis (RA). The start of this study confirms previously announced plans. "This head-to-head study is an important milestone. We believe that...

2011-11-30 11:30:00

ATLANTA, Nov. 30, 2011 /PRNewswire/ -- UCB, a leading biopharmaceutical company committed to the development of new epilepsy treatments and research, is proud to sponsor several key sets of Vimpat® (lacosamide) C-V data at the 65th Annual Meeting of the American Epilepsy Society (AES) in Baltimore, Md., December 2-6. "At UCB, we are committed to working toward improving the lives of people living with epilepsy," said Dr. James Zackheim, Senior Medical...

2011-11-30 09:00:00

ATLANTA, Nov. 30, 2011 /PRNewswire/ -- UCB, Inc., a leading biopharmaceutical company focused on immunology treatments and research, today announced the 30 recipients of the 2011 UCB Rheumatoid Arthritis Family Scholarship. This scholarship recognizes outstanding individuals from across the country who are pursuing higher education as part of their efforts to live beyond the limitations of rheumatoid arthritis. "UCB is dedicated to go beyond making a difference in the lives of...

2011-11-30 09:00:00

ATLANTA, Nov. 30, 2011 /PRNewswire/ -- UCB, Inc., a leading biopharmaceutical company at the forefront of immunology treatments and research, announced the 30 recipients of the 2011 UCB Crohn's and Me Scholarship. This scholarship recognizes outstanding individuals from across the country who are pursuing higher education as part of their efforts to live beyond the limitations of Crohn's disease. "UCB is committed to making a difference in the lives of people affected by Crohn's disease,"...

2011-11-17 09:00:00

ATLANTA, Nov. 17, 2011 /PRNewswire/ -- UCB, Inc. today announced 40 recipients of the 2011 UCB Family Epilepsy Scholarship, recognizing outstanding individuals from across the country who are pursuing higher education as part of their efforts to live beyond the limitations posed by epilepsy. Epilepsy is a chronic neurological condition affecting approximately three million people in the U.S. and 40 million people worldwide. "We appreciate the paramount value and importance of education...

2011-11-15 12:10:00

BOSTON, Nov. 15, 2011 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that it has been selected as one of two strategic partners by UCB, a global biopharmaceutical company, to provide clinical development services worldwide. PAREXEL will work with UCB to drive innovation and accelerate development, as well as to increase productivity and cost effectiveness. The agreement is effective for all of UCB's new...

2011-11-04 14:00:00

ATLANTA, Nov. 4, 2011 /PRNewswire/ -- UCB, a leading biopharmaceutical company at the forefront of immunology treatment and research, is marking the 2011 American College of Rheumatology (ACR) meeting by reinforcing its commitment to people living with rheumatoid arthritis (RA) and their healthcare providers. At this year's ACR meeting, UCB is proud to sponsor several key sets of data with new findings on patient-reported quality of life measures, including work and household productivity,...

2011-11-01 09:00:00

ATLANTA, Nov. 1, 2011 /PRNewswire/ -- In honor of Epilepsy Awareness Month, global biopharmaceutical company UCB, Inc. is enlisting the help of its Epilepsy Advocates to "start a revolution," by inspiring people impacted by epilepsy to speak out about the condition. As part of this effort, UCB will roll out a series of initiatives, including a nationwide grassroots campaign called "Army of Advocates" and two new Epilepsy Advocate Radio shows featuring a representative from HealthyWomen --...

2011-10-31 09:00:00

ATLANTA, Oct. 31, 2011 /PRNewswire/ -- UCB, a leading biopharmaceutical company at the forefront of immunology treatment and research, will present new data on Cimzia® (certolizumab pegol) at the American College of Gastroenterology (ACG) Annual Scientific Meeting, taking place in Washington D.C. from October 28 to November 2. "Cimzia data presented this year at ACG highlights the role that inflammatory biomarkers may play in increasing the understanding of the...